Riemser Arzneimittel AG Mergers and Acquisitions Summary

Life Science Company

Riemser Arzneimittel AG has acquired 2 companies of its own, including 1 in the last 5 years.

Riemser Arzneimittel AG has acquired in 2 countries. The Company’s most targeted sectors include leisure (50%) and medical products (50%).

Join Mergr and gain access to Riemser Arzneimittel AG’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Riemser Arzneimittel AG

An der Wiek 7,
Greifswald - Insel Riems, 17493
Germany,
+49 30 338427-0
www.riemser.de

Riemser Arzneimittel AG is a pharmaceutical company focuses on its activities is mainly due to the distribution and life cycle management of pharmaceuticals in therapeutic niche areas with high unmet medical needs. Riemser product range especially covers prescription drugs to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, in the cardiovascular field, in dermatology, rheumatology, tuberculosis treatment, for the treatment of obesity and primary axillary hyperhidrosis.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.2/yr) # 1 - - 1 - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Zaltanpharma Laboratories 2019-10-02 - Divestiture
Madrid, Spain · www.zaltanpharma.com
anwerina AG 2012-04-26 - Stake Purchase
Kreuzlingen, Switzerland
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Leisure 1 (50%) - - -
Medical Products 1 (50%) - - -
Total 2 - - -

By Geo

State/Country Buy Value Sell Value
Spain 1 - - -
Switzerland 1 - - -
Domestic - - - -
Cross-border 2 (100%) - - -
Total 2 - - -

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 159,764
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 148K M&A Transactions
  • 156K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 47K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.